Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma. - Wikidata - wikimedia - TriplyDB

Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.

Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.

http://www.wikidata.org/entity/Q34856899

about

Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challenges Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer A novel cancer testis antigen target A-kinase anchor protein (AKAP4) for the early diagnosis and immunotherapy of colon cancer Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma Detection of genome-wide copy number variations in two chicken lines divergently selected for abdominal fat content.Sperm-associated antigen 9 is a novel biomarker for colorectal cancer and is involved in tumor growth and tumorigenicity.A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer.The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma.Sperm associated antigen 9 (SPAG9) expression and humoral response in benign and malignant salivary gland tumors.Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraft.Anti-tumour effects of small interfering RNA targeting anion exchanger 1 in experimental gastric cancer.Cancer/testis antigens and urological malignancies Cancer testis antigens: A new paradigm for cancer therapy.Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.SPAG9 controls the cell motility, invasion and angiogenesis of human osteosarcoma cells.SPAG9 is involved in hepatocarcinoma cell migration and invasion via modulation of ELK1 expression.SPAG9 is overexpressed in osteosarcoma, and regulates cell proliferation and invasion through regulation of JunD.Down regulation of SPAG9 reduces growth and invasive potential of triple-negative breast cancer cells: possible implications in targeted therapy.β-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma.Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma.Targeting the testis-specific heat-shock protein 70-2 (HSP70-2) reduces cellular growth, migration, and invasion in renal cell carcinoma cells.Diversin is overexpressed in human gliomas and its depletion inhibits proliferation and invasion.Overexpression of SPAG9 correlates with poor prognosis and tumor progression in hepatocellular carcinoma.SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation.Hypoxia regulates the sperm associated antigen 4 (SPAG4) via HIF, which is expressed in renal clear cell carcinoma and promotes migration and invasion in vitro.SPAG9 is overexpressed in human astrocytoma and promotes cell proliferation and invasion.Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics.The cancer-retina antigen recoverin as a potential biomarker for renal tumors.Sperm-associated antigen 9 overexpression correlates with poor prognosis and insensitive to Taxol treatment in breast cancer.Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.Assessment of SPAG9 Transcript in Fine Needle Aspirates of Thyroid Nodules Serum levels of anti-sperm-associated antigen 9 antibody are elevated in patients with hepatocellular carcinoma.Sperm-associated antigen 9 is upregulated in hepatocellular carcinoma tissue and enhances QGY cell proliferation and invasion in vitro.AKAP4, SPAG9 and NY-ESO-1 in Iranian Colorectal Cancer Patients as Probable Diagnostic and Prognostic Biomarkers

P2860

Q26774074-A281B381-E1D0-4C15-A3FD-F3CFD088A2D1 Q28273809-262AD81C-3A15-4D84-97C5-902137B02184 Q28274654-191BCAC6-6D15-486D-A487-098BD603051A Q28304265-C94B2EE2-84BA-4A30-9251-D4999EE14BCA Q33883064-04C26582-2C88-4683-9847-52FA2BD4E0BA Q34167223-A5206639-88F8-454C-981E-9FC54E75D031 Q34330451-AC75F57A-322D-4655-811D-CF34FA58D29B Q34350624-C8C23931-EEE9-4D00-B093-77A0E1EAAD73 Q34475061-4E7386CD-D55F-493D-8C3A-9984CE439BD5 Q35055061-DFE56650-BA7B-4803-922D-14D7B175FD4D Q35657930-D321C8A2-9746-43F6-9A98-735B93234B43 Q36337004-034273B8-DF94-4EAC-9351-B07B7D8E8418 Q36388554-8659A197-163B-498D-B87E-2C6A27C81912 Q36485955-57018408-A5AE-4ED5-A5B0-B5FE558DA773 Q36524476-E31EB8B5-DC92-430B-AA52-90718EFDE103 Q36657565-E8999EF7-414C-45C3-83BD-704ED1022997 Q37289301-C4EABE09-4564-464B-802F-D1B50B342871 Q37359890-BE9A3223-B3BB-4DC6-B557-3578BBB3D129 Q37669551-3D3B4C2F-E54E-4874-A02F-C354E54BF35A Q38832513-7DDF6DA0-D101-493F-ABC3-70779BB9BA50 Q38957319-BEAF4170-0A47-4494-88E7-7C0E9CAB23F5 Q38994536-E462AA8A-A406-43FF-B048-A3251E954D2A Q38997891-18562CCD-C9E3-432E-8A2C-5F844B97EAB0 Q39003350-0EBED5E2-7F78-4C63-BC19-27145AE781E7 Q39131858-42D8AA41-4764-4607-BF76-5EAA1ABDD152 Q39148920-3CA25161-3DBE-401F-B136-FB26E15CFD0B Q39602023-EE5A3C81-C874-459F-B7BB-04F3FF631467 Q40058624-9FDEAA34-B4C1-4D6A-838D-BD42C67FD939 Q41077960-F2ACF3A9-6AED-42E9-8271-92603DEA2B90 Q41550563-BF2DF9FE-D7F1-42CD-8D42-17F6D678AB56 Q42101589-70AFC13C-756B-42B7-9C0A-F3D62B0CC129 Q47552142-474BB8E1-0250-42B6-B318-AB112709BC21 Q49386963-556A853E-2B69-486C-99D0-9C0453848C6B Q54974762-C604F6BF-7028-4B03-8B09-875782F7F451

P2860

Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.

http://www.wikidata.org/entity/Q34856899

description

2008 nî lūn-bûn

@nan

2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Sperm-associated antigen 9 is ...... asion in renal cell carcinoma.

@ast

Sperm-associated antigen 9 is ...... asion in renal cell carcinoma.

@en

Sperm-associated antigen 9 is ...... asion in renal cell carcinoma.

@nl

type

label

Sperm-associated antigen 9 is ...... asion in renal cell carcinoma.

@ast

Sperm-associated antigen 9 is ...... asion in renal cell carcinoma.

@en

Sperm-associated antigen 9 is ...... asion in renal cell carcinoma.

@nl

prefLabel

Sperm-associated antigen 9 is ...... asion in renal cell carcinoma.

@ast

Sperm-associated antigen 9 is ...... asion in renal cell carcinoma.

@en

Sperm-associated antigen 9 is ...... asion in renal cell carcinoma.

@nl

P1433

Q34856899-A6BB6A70-58CE-4F57-8296-B1C40FE5D399

P1476

Q34856899-D227561D-17C7-4627-A800-9EF99522986B

P2093

Q34856899-0669BF47-D159-437F-AF96-C42A5627E6C5

Q34856899-198A5562-63A8-402A-9FD2-3FDDA3EFC90A

Q34856899-1DDD7962-7625-4550-9F8B-E8BF5CB3A9C9

Q34856899-3B0AAAEC-0A62-4858-95D4-C2378E2EA0C3

Q34856899-49EAA926-A28B-4C45-ADD0-D7A7EDD27CB7

Q34856899-71B22984-784C-40CA-8413-C6ADFE9FDF2E

Q34856899-D3F4DB96-B669-4B0D-A067-C5C12D1EAA9C

Q34856899-E3C330D8-1276-4AB8-8AD3-0E69A9D19CFE

Q34856899-ED9D79E1-7D4E-4DAF-9C71-66A03D66AFCD

Q34856899-F493285E-6DE4-448D-8121-62BE36C559B2

P304

Q34856899-FECC5ADF-585A-444E-88D5-A59CFF1CFDCF

P31

Q34856899-B0611E51-48C6-4759-AE6F-3726E2CC4356

P356

Q34856899-70A579C1-C79F-413C-9DEE-4ACE5F0704B5

P407

Q34856899-1803FA80-FD12-4574-BB33-B85792457E71

P433

Q34856899-6E7B16D0-8729-4646-A799-6A7B284289AE

P478

Q34856899-DF652BBD-4BAB-4B0E-B77A-49508E5B6A26

P50

Q34856899-B2B64246-7431-4121-A307-87E334078F9A

Q34856899-F2CF2A71-41A7-4B18-ACA7-4AB509D86CAA

Q34856899-F6D276DC-2BA6-4162-A7E5-A7069253F118

P577

Q34856899-D36E6349-2B27-4221-AA04-63518702877E

P698

Q34856899-C24A2A9E-66CA-4B01-B238-38C5D19C1148

P356

0008-5472.CAN-08-1708

P1433

Cancer Research

P1476

Sperm-associated antigen 9 is ...... vasion in renal cell carcinoma

@en

P2093

Amlesh Seth

http://www.w3.org/2001/XMLSchema#string

Anju Gupta

http://www.w3.org/2001/XMLSchema#string

Deepika Kanojia

http://www.w3.org/2001/XMLSchema#string

Dipak Chaurasiya

http://www.w3.org/2001/XMLSchema#string

Namrata Dudha

http://www.w3.org/2001/XMLSchema#string

Nirmal Kumar Lohiya

http://www.w3.org/2001/XMLSchema#string

Nirmala Jagadish

http://www.w3.org/2001/XMLSchema#string

Rajive Kumar

http://www.w3.org/2001/XMLSchema#string

Samir Gupta

http://www.w3.org/2001/XMLSchema#string

Satish Sati

http://www.w3.org/2001/XMLSchema#string

P304

8240-8248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-1708

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

68

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18922895

http://www.w3.org/2001/XMLSchema#string